Inhaled corticosteroids as combination therapy with β-adrenergic agonists in airways disease: Present and future

European Journal of Clinical Pharmacology

Volumn 65, Issue 9, 2009, Pages 853-871

  Chung, Kian Fan ^a   Caramori, Gaetano ^a,b   Adcock, Ian M ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b UNIVERSITY OF FERRARA   (Italy)

Author keywords

Asthma; Beta adrenergic agonists; Chronic obstructive pulmonary disease; Corticosteroids; Inflammation

Indexed keywords

BECLOMETASONE DIPROPIONATE; BECLOMETHASONE PLUS FORMOTEROL; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; BUDESONIDE PLUS FORMOTEROL; CHEMOKINE; CICLESONIDE; CORTICOSTEROID; CYTOKINE; DEXAMETHASONE; FLUNISOLIDE; FLUTICASONE; FLUTICASONE PROPIONATE; FLUTICASONE PROPIONATE PLUS SALMETEROL; FORMOTEROL; GLUCOCORTICOID RECEPTOR; GLUCOCORTICOID RECEPTOR BETA; HISTONE DEACETYLASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; METHACHOLINE; MITOGEN ACTIVATED PROTEIN KINASE; MOMETASONE FUROATE; NEDOCROMIL SODIUM; PLACEBO; PREDNISOLONE; SALMETEROL; TRIAMCINOLONE; TRIAMCINOLONE ACETATE; TRIAMCINOLONE ACETONIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIINFLAMMATORY ACTIVITY; ASTHMA; BINDING AFFINITY; BIOAVAILABILITY; BONE DENSITOMETRY; BONE DENSITY; CATARACT; CHRONIC INFLAMMATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; COUGHING; CYTOKINE RELEASE; DISEASE EXACERBATION; DOSE RESPONSE; DRUG ABSORPTION; DRUG DNA BINDING; DRUG DOSE INCREASE; DRUG EFFECT; DRUG EFFICACY; DRUG FATALITY; DRUG MECHANISM; DRUG MEGADOSE; DRUG METABOLISM; DRUG POTENCY; DRUG POTENTIATION; DRUG RECEPTOR BINDING; DRUG RESPONSE; DYSPHONIA; DYSPNEA; FORCED EXPIRATORY VOLUME; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENOMICS; GLAUCOMA; HIP FRACTURE; HOARSENESS; HUMAN; HYPERGLYCEMIA; INFLAMMATORY CELL; INJURY; LOW DRUG DOSE; LUNG FUNCTION; MOLECULAR INTERACTION; MORTALITY; NEUTROPHIL COUNT; OSTEOPENIA; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUALITY OF LIFE; RESPIRATORY TRACT DISEASE; REVIEW; RISK REDUCTION; SIDE EFFECT; THRUSH; TREMOR; UNSPECIFIED SIDE EFFECT;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ADRENERGIC BETA-AGONISTS; ANTI-ASTHMATIC AGENTS; ANTI-INFLAMMATORY AGENTS; ASTHMA; BIOLOGICAL AVAILABILITY; BONE AND BONES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; DRUG TOLERANCE; FRACTURES, BONE; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECURRENCE; SEVERITY OF ILLNESS INDEX;

EID: 69249222635     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-009-0682-z     Document Type: Review

References (221)

1. K Ito KF Chung IM Adcock 2006 Update on glucocorticoid action and resistance J Allergy Clin Immunol 117 522 543
2. NL Weigel NL Moore 2007 Steroid receptor phosphorylation: a key modulator of multiple receptor functions Mol Endocrinol 21 2311 2319
3. IM Adcock PJ Barnes 2008 Molecular mechanisms of corticosteroid resistance Chest 134 394 401
4. B Li M Carey JL Workman 2007 The role of chromatin during transcription Cell 128 707 719
5. AY So C Chaivorapol EC Bolton H Li KR Yamamoto 2007 Determinants of cell- and gene-specific transcriptional regulation by the glucocorticoid receptor PLoS Genet 3 e94
6. E Xystrakis S Kusumakar S Boswell E Peek Z Urry DF Richards T Adikibi C Pridgeon M Dallman TK Loke, et al. 2006 Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients J Clin Invest 116 146 155
7. K Ito KF Chung IM Adcock 2006 Update on glucocorticoid action and resistance J Allergy Clin Immunol 117 522 543
8. BK De CK Van OC Meijer G Haegeman 2008 Selective transrepression versus transactivation mechanisms by glucocorticoid receptor modulators in stress and immune systems Eur J Pharmacol 583 290 302
9. M Nie AJ Knox L Pang 2005 Beta2-adrenoceptor agonists, like glucocorticoids, repress eotaxin gene transcription by selective inhibition of histone H4 acetylation J Immunol 175 478 486
10. AR Clark JR Martins CR Tchen 2008 Role of dual specificity phosphatases in biological responses to glucocorticoids J Biol Chem 283 25765 25769
11. P Bhavsar M Hew N Khorasani A Torrego PJ Barnes I Adcock KF Chung 2008 Relative corticosteroid insensitivity of alveolar macrophages in severe asthma compared with non-severe asthma Thorax 63 784 790
12. S Meyer C Temme E Wahle 2004 Messenger RNA turnover in eukaryotes: pathways and enzymes Crit Rev Biochem Mol Biol 39 197 216
13. G Horvath A Wanner 2006 Inhaled corticosteroids: effects on the airway vasculature in bronchial asthma Eur Respir J 27 172 187
14. AW Norman MT Mizwicki DP Norman 2004 Steroid-hormone rapid actions, membrane receptors and a conformational ensemble model Nat Rev Drug Discov 3 27 41
15. JD Croxtall Q Choudhury RJ Flower 2000 Glucocorticoids act within minutes to inhibit recruitment of signalling factors to activated EGF receptors through a receptor-dependent, transcription-independent mechanism Br J Pharmacol 130 289 298
16. PK Jeffery RW Godfrey E Adelroth F Nelson A Rogers SA Johansson 1992 Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma A quantitative light and electron microscopic study. Am Rev Respir Dis 145 890 899
17. E Adelroth L Rosenhall S-A Johansson M Linden P Venge 1990 Inflammatory cells and eosinophilic activity in asthmatics investigated by bronchoalveolar lavage: the effects of antiasthmatic treatment with budesonide or terbutaline Am Rev Respir Dis 142 91 99
18. LA Laitinen A Laitinen T Haahtele 1992 A comparative study of the effects of an inhaled corticosteroid, budesemide, and of a β2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma J Allergy Clin Immunol 90 32 42
19. LC Laursen E Taudorf S Borgeskov T Kobayasi H Jensen B Weeke 1988 Fiberoptic bronchoscopy and bronchial mucosal biopsies in asthmatics undergoing long-term high-dose budesonide aerosol treatment Allergy 43 284 288
20. R Djukanovic JW Wilson KM Britten SJ Wilson AF Walls WR Roche PH Howarth ST Holgate 1992 The effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma Am Rev Respir Dis 145 669 674
21. EL van Rensen KC Straathof MA Veselic-Charvat AH Zwinderman EH Bel PJ Sterk 1999 Effect of inhaled steroids on airway hyperresponsiveness, sputum eosinophils, and exhaled nitric oxide levels in patients with asthma Thorax 54 403 408
22. D Olivieri A Chetta M Del Donno G Bertorelli A Casalini A Pesci R Testi A Foresi 1997 Effect of short-term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodeling in mild asthma: a placebo-controlled study Am J Respir Crit Care Med 155 1864 1871
23. BE Orsida X Li B Hickey F Thien JW Wilson EH Walters 1999 Vascularity in asthmatic airways: relation to inhaled steroid dose Thorax 54 289 295
24. JL Brieva I Danta A Wanner 2000 Effect of an inhaled glucocorticosteroid on airway mucosal blood flow in mild asthma Am J Respir Crit Care Med 161 293 296 (Pubitemid 30055939)
25. JK Sont LN Willems EH Bel JH van Krieken JP Vandenbroucke PJ Sterk 1999 Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group Am J Respir Crit Care Med 159 1043 1051
26. PG Gibson BJ Wong MJ Hepperle PA Kline A Girgis-Gabardo G Guyatt J Dolovich JA Denburg EH Ramsdale FE Hargreave 1992 A research method to induce and examine a mild exacerbation of asthma by withdrawal of inhaled corticosteroid Clin Exp Allergy 22 525 532
27. C in't Veen HH Smits PS Hiemstra AE Zwinderman PJ Sterk EH Bel 1999 Lung function and sputum characteristics of patients with severe asthma during an induced exacerbation by double-blind steroid withdrawal Am J Respir Crit Care Med 160 93 99
28. PJ Barnes 1995 Inhaled glucocorticoids for asthma N Engl J Med 332 868 875
29. SP Umland RP Schleimer SL Johnston 2002 Review of the molecular and cellular mechanisms of action of glucocorticoids for use in asthma Pulm Pharmacol Ther 15 35 50
30. RP Schleimer BS Bochner 1994 The effects of glucocorticoids on human eosinophils J Allergy Clin Immunol 94 1202 1213
31. RP Schleimer 1993 An overview of glucocorticoid anti-inflammatory actions Eur J Clin Pharmacol 45 Suppl 1 S3 S7
32. SP Peters RM Naclerio RP Schleimer DW MacGlashan Jr U Pipkorn LM Lichtenstein 1986 The pharmacologic control of mediator release from human basophils and mast cells Respiration 50 Suppl 2 116 122
33. R Djukanovic JW Wilson KM Britten SJ Wilson AF Walls WR Roche PH Howarth ST Holgate 1992 Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma Am Rev Respir Dis 145 669 674
34. M Majori ML Piccoli S Bertacco A Cuomo L Cantini A Pesci 1997 Inhaled beclomethasone dipropionate downregulates CD4 and CD8 T-lymphocyte activation in peripheral blood of patients with asthma J Allergy Clin Immunol 100 379 382
35. JW Wilson R Djukanovic PH Howarth ST Holgate 1994 Inhaled beclomethasone dipropionate downregulates airway lymphocyte activation in atopic asthma Am J Respir Crit Care Med 149 86 90
36. L Borish JJ Mascali J Dishuck WR Beam RJ Martin LJ Rosenwasser 1992 Detection of alveolar macrophage-derived IL-1 beta in asthma Inhibition with corticosteroids. J Immunol 149 3078 3082
37. R Dworski GA Fitzgerald JA Oates JR Sheller 1994 Effect of oral prednisone on airway inflammatory mediators in atopic asthma Am J Respir Crit Care Med 149 953 959
38. SE Wenzel SJ Szefler DYM Leung SI Sloan MD Rex RJ Martin 1997 Bronchoscopic evaluation of severe asthma: persistent inflammation associated with high dose glucocorticoids Amer J Respir Crit Care Med 156 737 743
39. G Cox 1995 Glucocorticoid treatment inhibits apoptosis in human neutrophils Separation of survival and activation outcomes. J Immunol 154 4719 4725
40. RP Schleimer HS Freeland SP Peters KE Brown CP Derse 1989 An assessment of the effects of glucocorticoids on degranulation, chemotaxis, binding to vascular endothelium and formation of leukotriene B4 by purified human neutrophils J Pharmacol Exp Ther 250 598 605
41. SA Kharitonov DH Yates KF Chung PJ Barnes 1996 Changes in the dose of inhaled steroid affect exhaled nitric oxide levels in asthmatic patients Eur Respir J 9 196 201
42. KF Chung PJ Barnes 1999 Cytokines in asthma Thorax 54 825 857
43. Chung KF (2008) Asthma treatments: effects on the airway smooth muscle. In: Chung KF (ed) Airway smooth muscle in asthma and COPD: biology and pharmacology. John Wiley & Sons, Chichester, pp 277-302
44. M John S Lim J Seybold P Jose A Robichaud B O'Connor PJ Barnes KF Chung 1998 Inhaled corticosteroids increase interleukin-10 but reduce macrophage inflammatory protein-1alpha, granulocyte-macrophage colony-stimulating factor, and interferon-gamma release from alveolar macrophages in asthma Am J Respir Crit Care Med 157 256 262
45. AR Sousa CJ Trigg SJ Lane R Hawksworth JA Nakhosteen RN Poston TH Lee 1997 Effect of inhaled glucocorticoids on IL-1 beta and IL-1 receptor antagonist (IL-1 ra) expression in asthmatic bronchial epithelium Thorax 52 407 410
46. KF Chung 1986 Role played by inflammation in the hyperreactivity of the airways in asthma Thorax 41 657 662
47. EF Juniper PA Kline MA Vanzieleghem EH Ramsdale PM O'Byrne FE Hargreave 1990 Effect of a long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthma Am Rev Respir Dis 142 832 836
48. C Ward M Pais R Bish D Reid B Feltis D Johns EH Walters 2002 Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma Thorax 57 309 316
49. AS Vathenen AJ Knox A Wisniewski AE Tattersfield 1991 Effect of inhaled budesonide on bronchial reactivity to histamine, exercise and encepnic dry air hyperventilation in patients with asthma Thorax 46 811 816
50. PJ Barnes 1990 Effect of corticosteroids on airway hyperresponsiveness Am Rev Respir Dis 141 S70 S76
51. M van den Berge HA Kerstjens RJ Meijer DM de Reus GH Koeter HF Kauffman DS Postma 2001 Corticosteroid-induced improvement in the PC20 of adenosine monophosphate is more closely associated with reduction in airway inflammation than improvement in the PC20 of methacholine Am J Respir Crit Care Med 164 1127 1132 (Pubitemid 33052238)
52. EH Bel MC Timmers AH Zwinderman JH Dijkman PJ Sterk 1991 The effect of inhaled corticosteroids on the maximal degree of airway narrowing to methacholine in asthmatic subjects Am Rev Respir Dis 143 109 113
53. AS Vathenen AJ Knox A Wisniewski AE Tattersfield 1991 Time course of change in bronchial reactivity with an inhaled corticosteroid in asthma Am Rev Respir Dis 143 1317 1321
54. T Haahtela M Jarvinen T Kava K Kiviranta S Koskinen K Lehtonen K Nikander T Persson O Selroos A Sovijarvi, et al. 1994 Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma N Engl J Med 331 700 705
55. EF Juniper PA Kline MA Vanzieleghem FE Hargreave 1991 Reduction of budesonide after a year of increased use: a randomized controlled trial to evaluate whether improvements in airway responsiveness and clinical asthma are maintained J Allergy Clin Immunol 87 483 489
56. PJ Barnes 2000 Chronic obstructive pulmonary disease N Engl J Med 343 269 280
57. KF Rabe S Hurd A Anzueto PJ Barnes SA Buist P Calverley Y Fukuchi C Jenkins R Rodriguez-Roisin C Van Weel, et al. 2007 Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary Am J Respir Crit Care Med 176 532 555
58. JC Hogg F Chu S Utokaparch R Woods WM Elliott L Buzatu RM Cherniack RM Rogers FC Sciurba HO Coxson, et al. 2004 The nature of small-airway obstruction in chronic obstructive pulmonary disease N Engl J Med 350 2645 2653
59. M Saetta G Turato P Maestrelli CE Mapp LM Fabbri 2001 Cellular and structural bases of chronic obstructive pulmonary disease Am. J Respir Crit Care Med 163 1304 1309
60. KF Chung IM Adcock 2008 Multi-faceted mechanism in COPD: inflammation, immunity and tissue repair and destruction Eur Respir J 31 1334 1356
61. WQ Gan P Man DD Sin 2005 Effects of inhaled corticosteroids on sputum cell counts in stable chronic obstructive pulmonary disease: a systematic review and a meta-analysis BMC Pulm Med 5 3 3
62. M Boorsma R Lutter MA van de Pol TA Out HM Jansen RE Jonkers 2008 Long-term effects of budesonide on inflammatory status in COPD COPD 5 97 104
63. P Chanez AM Vignola T O'Shaugnessy I Enander D Li PK Jeffery J Bousquet 1997 Corticosteroid reversibility in COPD is related to features of asthma Am J Respir Crit Care Med 155 1529 1534 (Pubitemid 27216654)
64. CE Brightling W Monteiro R Ward D Parker MD Morgan AJ Wardlaw ID Pavord 2000 Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial Lancet 356 1480 1485
65. KL Hattotuwa MJ Gizycki TW Ansari PK Jeffery NC Barnes 2002 The effects of inhaled fluticasone on airway inflammation in chronic obstructive pulmonary disease: a double-blind, placebo-controlled biopsy study Am J Respir Crit Care Med 165 1592 1596
66. MJ Gizycki KL Hattotuwa N Barnes PK Jeffery 2002 Effects of fluticasone propionate on inflammatory cells in COPD: an ultrastructural examination of endobronchial biopsy tissue Thorax 57 799 803
67. NC Barnes YS Qiu ID Pavord D Parker PA Davis J Zhu M Johnson NC Thomson PK Jeffery 2006 Antiinflammatory effects of salmeterol/fluticasone propionate in chronic obstructive lung disease Am J Respir Crit Care Med 173 736 743
68. DD Sin SF Man DD Marciniuk G Ford M Fitzgerald E Wong E York RR Mainra W Ramesh LS Melenka, et al. 2008 The effects of fluticasone with or without salmeterol on systemic biomarkers of inflammation in chronic obstructive pulmonary disease Am J Respir Crit Care Med 177 1207 1214
69. SF Man DD Sin 2005 Effects of corticosteroids on systemic inflammation in chronic obstructive pulmonary disease Proc Am Thorac Soc 2 78 82
70. IM Adcock K Maneechotesuwan O Usmani 2002 Molecular interactions between glucocorticoids and long-acting beta2-agonists J Allergy Clin Immunol 110 S261 S268
71. OS Usmani K Ito K Maneechotesuwan M Ito M Johnson PJ Barnes IM Adcock 2005 Glucocorticoid receptor nuclear translocation in airway cells after inhaled combination therapy Am J Respir Crit Care Med 172 704 712
72. M Roth PR Johnson JJ Rudiger GG King Q Ge JK Burgess G Anderson M Tamm JL Black 2002 Interaction between glucocorticoids and beta2 agonists on bronchial airway smooth muscle cells through synchronised cellular signalling Lancet 360 1293 1299
73. KF Chung IM Adcock 2004 Combination therapy of long-acting beta2-adrenoceptor agonists and corticosteroids for asthma Treat Respir Med 3 279 289
74. DD Sin SF Man 2006 Corticosteroids and adrenoceptor agonists: the compliments for combination therapy in chronic airways diseases Eur J Pharmacol 533 28 35
75. WC Moore ER Bleecker D Curran-Everett SC Erzurum BT Ameredes L Bacharier WJ Calhoun M Castro KF Chung MP Clark, et al. 2007 Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program J Allergy Clin Immunol 119 405 413
76. D Bumbacea D Campbell L Nguyen D Carr PJ Barnes D Robinson KF Chung 2004 Parameters associated with persistent airflow obstruction in chronic severe asthma Eur Respir J 24 122 128
77. DS Robinson DA Campbell SR Durham J Pfeffer PJ Barnes KF Chung 2003 Systematic assessment of difficult-to-treat asthma Eur Respir J 22 478 483
78. A Jatakanon C Uasuf W Maziak S Lim KF Chung PJ Barnes 1999 Neutrophilic inflammation in severe persistent asthma Am J Respir Crit Care Med 160 1532 1539
79. SE Wenzel LB Schwartz EL Langmack JL Halliday JB Trudeau RL Gibbs HW Chu 1999 Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics Am J Respir Crit Care Med 160 1001 1008
80. L Benayoun A Druilhe MC Dombret M Aubier M Pretolani 2003 Airway structural alterations selectively associated with severe asthma Am J Respir Crit Care Med 167 1360 1368
81. A Bourdin D Neveu I Vachier F Paganin P Godard P Chanez 2007 Specificity of basement membrane thickening in severe asthma J Allergy Clin Immunol 119 1367 1374
82. L Cohen E Xueping J Tarsi T Ramkumar TK Horiuchi R Cochran S DeMartino KB Schechtman I Hussain MJ Holtzman, et al. 2007 Epithelial cell proliferation contributes to airway remodeling in severe asthma Am J Respir Crit Care Med 176 138 145
83. M Hew P Bhavsar A Torrego S Meah N Khorasani PJ Barnes I Adcock CK Fan 2006 Relative corticosteroid insensitivity of peripheral blood mononuclear cells in severe asthma Am J Respir Crit Care Med 174 134 141
84. SV Culpitt DF Rogers P Shah C De Matos REK Russell LE Donnelly PJ Barnes 2003 Impaired inhibition by dexamethasone of cytokine release by alveolar macrophages from patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 167 24 31
85. K Ito M Ito WM Elliott B Cosio G Caramori OM Kon A Barczyk S Hayashi IM Adcock JC Hogg, et al. 2005 Decreased histone deacetylase activity in chronic obstructive pulmonary disease N Engl J Med 352 1967 1976 (Pubitemid 40638367)
86. C Marban S Suzanne F Dequiedt S de Walque L Redel C Van Lint D Aunis O Rohr 2007 Recruitment of chromatin-modifying enzymes by CTIP2 promotes HIV-1 transcriptional silencing EMBO J 26 412 423
87. P Szulakowski AJ Crowther LA Jimenez K Donaldson R Mayer TB Leonard W [tmp] MacNee EM Drost 2006 The effect of smoking on the transcriptional regulation of lung inflammation in patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 174 41 50
88. K Ito S Lim G Caramori B Cosio KF Chung IM Adcock PJ Barnes 2002 A molecular mechanism of action of theophylline: induction of histone deacetylase activity to decrease inflammatory gene expression Proc Natl Acad Sci USA 99 8921 8926
89. K Ito S Yamamura S Essilfie-Quaye B Cosio M Ito PJ Barnes IM Adcock 2006 Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-kappaB suppression J Exp Med 203 7 13
90. DY Leung RJ Martin SJ Szefler ER Sher S Ying AB Kay Q Hamid 1995 Dysregulation of interleukin 4, interleukin 5, and interferon gamma gene expression in steroid-resistant asthma J Exp Med 181 33 40
91. E Irusen JG Matthews A Takahashi PJ Barnes KF Chung IM Adcock 2002 p38 Mitogen-activated protein kinase-induced glucocorticoid receptor phosphorylation reduces its activity: role in steroid-insensitive asthma J Allergy Clin Immunol 109 649 657
92. JC Webster RH Oakley CM Jewell JA Cidlowski 2001 Proinflammatory cytokines regulate human glucocorticoid receptor gene expression and lead to the accumulation of the dominant negative beta isoform: a mechanism for the generation of glucocorticoid resistance Proc Natl Acad Sci USA 98 6865 6870
93. E Goleva LB Li PT Eves MJ Strand RJ Martin DY Leung 2006 Increased glucocorticoid receptor beta alters steroid response in glucocorticoid- insensitive asthma Am J Respir Crit Care Med 173 607 616
94. SJ Lane IM Adcock D Richards C Hawrylowicz PJ Barnes TH Lee 1998 Corticosteroid-resistant bronchial asthma is associated with increased c-fos expression in monocytes and T lymphocytes J Clin Invest 102 2156 2164
95. PJ Barnes K Ito IM Adcock 2004 Corticosteroid resistance in chronic obstructive pulmonary disease: inactivation of histone deacetylase Lancet 363 731 733
96. K Ito S Yamamura S Essilfie-Quaye B Cosio M Ito PJ Barnes IM Adcock 2006 Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-kappaB suppression J Exp Med 203 7 13
97. CM Hawrylowicz 2005 Regulatory T cells and IL-10 in allergic inflammation J Exp Med 202 1459 1463
98. K Biggadike I Uings SN Farrow 2004 Designing corticosteroid drugs for pulmonary selectivity Proc Am Thorac Soc 1 352 355
99. M Johnson 1996 Pharmacodynamics and pharmacokinetics of inhaled glucocorticoids J Allergy Clin Immunol 97 169 176
100. J Winkler G Hochhaus H Derendorf 2004 How the lung handles drugs: pharmacokinetics and pharmacodynamics of inhaled corticosteroids Proc Am Thorac Soc 1 356 363
101. A Valotis P Hogger 2007 Human receptor kinetics and lung tissue retention of the enhanced-affinity glucocorticoid fluticasone furoate Respir Res 8 54
102. TW Harrison A Wisniewski J Honour AE Tattersfield 2001 Comparison of the systemic effects of fluticasone propionate and budesonide given by dry powder inhaler in healthy and asthmatic subjects Thorax 56 186 191
103. TW Harrison AE Tattersfield 2003 Plasma concentrations of fluticasone propionate and budesonide following inhalation from dry powder inhalers by healthy and asthmatic subjects Thorax 58 258 260
104. TW Harrison 2001 Systemic availability of inhaled budesonide and fluticasone propionate: healthy versus asthmatic lungs BioDrugs 15 405 411
105. NP Adams PW Jones 2006 The dose-response characteristics of inhaled corticosteroids when used to treat asthma: an overview of Cochrane systematic reviews Respir Med 100 1297 1306
106. Adams NP, Bestall JC, Jones P, Lasserson TJ, Griffiths B, Cates CJ (2008) Fluticasone at different doses for chronic asthma in adults and children. Cochrane Database Syst Rev CD003534
107. DA Mahler P Wire D Horstman CN Chang J Yates T Fischer T Shah 2002 Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary disease Am J Respir Crit Care Med 166 1084 1091
108. NA Hanania P Darken D Horstman C Reisner B Lee S Davis T Shah 2003 The efficacy and safety of fluticasone propionate (250 microg)/salmeterol (50 microg) combined in the Diskus inhaler for the treatment of COPD Chest 124 834 843
109. P Calverley R Pauwels J Vestbo P Jones N Pride A Gulsvik J Anderson C Maden 2003 Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial Lancet 361 449 456
110. S Salmeron JC Guerin P Godard D Renon M Henry-Amar P Duroux A Taytard 1989 High doses of inhaled corticosteroids in unstable chronic asthma. A multicenter, double-blind, placebo-controlled study Am Rev Respir Dis 140 167 171
111. T Haahtela M Jarvinen T Kava K Kiviranta S Koskinen K Lehtonen K Nikander T Persson K Reinikainen O Selroos, et al. 1991 Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma [see comments] N Engl J Med 325 388 392
112. RA Pauwels S Pedersen WW Busse WC Tan YZ Chen SV Ohlsson A Ullman CJ Lamm PM O'Byrne 2003 Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial Lancet 361 1071 1076
113. (2000) Long-term effects of budesonide or nedocromil in children with asthma. The Childhood Asthma Management Program Research Group. N Engl J Med 343:1054-1063
114. PM O'Byrne PJ Barnes R Rodriguez-Roisin E Runnerstrom T Sandstrom K Svensson A Tattersfield 2001 Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial Am J Respir Crit Care Med 164 1392 1397
115. E Israel PS Chervinsky B Friedman J van Bavel CS Skalky AF Ghannam SR Bird JM Edelman 2002 Effects of montelukast and beclomethasone on airway function and asthma control J Allergy Clin Immunol 110 847 854
116. RA Baumgartner G Martinez JM Edelman GG Rodriguez Gomez M Bernstein S Bird R Angner A Polis SB Dass S Lu, et al. 2003 Distribution of therapeutic response in asthma control between oral montelukast and inhaled beclomethasone Eur Respir J 21 123 128
117. A Papi GW Canonica P Maestrelli P Paggiaro D Olivieri E Pozzi N Crimi AM Vignola P Morelli G Nicolini, et al. 2007 Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma N Engl J Med 356 2040 2052
118. HA Boushey CA Sorkness TS King SD Sullivan JV Fahy SC Lazarus VM Chinchilli TJ Craig EA Dimango A Deykin, et al. 2005 Daily versus as-needed corticosteroids for mild persistent asthma N Engl J Med 352 1519 1528
119. RJ Martin SJ Szefler TS King M Kraft HA Boushey VM Chinchilli TJ Craig EA Dimango A Deykin JV Fahy, et al. 2007 The Predicting Response to Inhaled Corticosteroid Efficacy (PRICE) trial J Allergy Clin Immunol 119 73 80
120. SC Lazarus VM Chinchilli NJ Rollings HA Boushey R Cherniack TJ Craig A Deykin E DiMango JE Fish JG Ford, et al. 2007 Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma Am J Respir Crit Care Med 175 783 790
121. GW Chalmers KJ MacLeod SA Little LJ Thomson CP McSharry NC Thomson 2002 Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma Thorax 57 226 230
122. M Duong G Gauvreau R Watson G Obminski T Strinich M Evans K Howie K Killian PM O'Byrne 2007 The effects of inhaled budesonide and formoterol in combination and alone when given directly after allergen challenge J Allergy Clin Immunol 119 322 327
123. DD Sin J Man H Sharpe WQ Gan SF Man 2004 Pharmacological management to reduce exacerbations in adults with asthma: a systematic review and meta-analysis JAMA 292 367 376
124. Greenstone IR, Ni Chroinin MN, Masse V, Danish A, Magdalinos H, Zhang X, Ducharme FM (2005) Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma. Cochrane Database Syst Rev CD005533
125. PM O'Byrne H Bisgaard PP Godard M Pistolesi M Palmqvist Y Zhu T Ekstrom ED Bateman 2005 Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma Am J Respir Crit Care Med 171 129 136
126. A Woolcock B Lundback N Ringdal LA Jacques 1996 Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids Am J Respir Crit Care Med 153 1481 1488
127. O Zetterstrom R Buhl H Mellem M Perpina J Hedman S O'Neill T Ekstrom 2001 Improved asthma control with budesonide/formoterol in a single inhaler, compared with budesonide alone Eur Respir J 18 262 268
128. ED Bateman HA Boushey J Bousquet WW Busse TJ Clark RA Pauwels SE Pedersen 2004 Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study Am J Respir Crit Care Med 170 836 844
129. RA Pauwels C Lofdahl D Postma A Tattersfield P O'Byrne PJ Barnes A Ullman 1997 Effect of inhaled formoterol and budesonide on exacerbations of asthma N Engl J Med 337 1405 1411
130. SE Overbeek PG Mulder SM Baelemans HC Hoogsteden JB Prins 2005 Formoterol added to low-dose budesonide has no additional antiinflammatory effect in asthmatic patients Chest 128 1121 1127
131. JG Koopmans R Lutter HM Jansen JS van der Zee 2006 Adding salmeterol to an inhaled corticosteroid: long term effects on bronchial inflammation in asthma Thorax 61 306 312
132. JG Koopmans R Lutter HM Jansen JS van der Zee 2005 Adding salmeterol to an inhaled corticosteroid reduces allergen-induced serum IL-5 and peripheral blood eosinophils J Allergy Clin Immunol 116 1007 1013
133. KF Rabe T Atienza P Magyar P Larsson C Jorup UG Lalloo 2006 Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study Lancet 368 744 753
134. ED Bateman L Jacques C Goldfrad T Atienza T Mihaescu M Duggan 2006 Asthma control can be maintained when fluticasone propionate/salmeterol in a single inhaler is stepped down J Allergy Clin Immunol 117 563 570
135. J Lotvall S Langley A Woodcock 2006 Inhaled steroid/long-acting beta 2 agonist combination products provide 24 hours improvement in lung function in adult asthmatic patients Respir Res 7 110
136. WY Tarsin SB Pearson KH Assi H Chrystyn 2006 Emitted dose estimates from Seretide Diskus and Symbicort Turbuhaler following inhalation by severe asthmatics Int J Pharm 316 131 137
137. C Vogelmeier A D'Urzo R Pauwels JM Merino M Jaspal S Boutet I Naya D Price 2005 Budesonide/formoterol maintenance and reliever therapy: an effective asthma treatment option? Eur Respir J 26 819 828
138. JM Fitzgerald LP Boulet RM Follows 2005 The CONCEPT trial: a 1-year, multicenter, randomized, double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma Clin Ther 27 393 406
139. A Papi PL Paggiaro G Nicolini AM Vignola LM Fabbri 2007 Beclomethasone/formoterol versus budesonide/formoterol combination therapy in asthma Eur Respir J 29 682 689 (Pubitemid 46554617)
140. J Bousquet LP Boulet MJ Peters H Magnussen J Quiralte NE Martinez-Aguilar A Carlsheimer 2007 Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone Respir Med 101 2437 2446
141. G Huchon H Magnussen A Chuchalin L Dymek FB Gonod J Bousquet 2009 Lung function and asthma control with beclomethasone and formoterol in a single inhaler Respir Med 103 41 49
142. PS Burge PM Calverley PW Jones S Spencer JA Anderson TK Maslen 2000 Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial Br Med J 320 1297 1303
143. E Israel TR Banerjee GM Fitzmaurice TV Kotlov K LaHive MS LeBoff 2001 Effects of inhaled glucocorticoids on bone density in premenopausal women N Engl J Med 345 941 947
144. RA Pauwels AS Buist PM Calverley CR Jenkins SS Hurd 2001 Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary Am J Respir Crit Care Med 163 1256 1276
145. SV Culpitt W Maziak S Loukidis JA Nightingale JL Matthews PJ Barnes 1999 Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease Am J Respir Crit Care Med 160 1635 1639
146. VM Keatings A Jatakanon YM Worsdell PJ Barnes 1997 Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD Am J Respir Crit Care Med 155 542 548
147. J Vestbo T Sorensen P Lange A Brix P Torre K Viskum 1999 Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial Lancet 353 1819 1823
148. RA Pauwels CG Lofdahl LA Laitinen JP Schouten DS Postma NB Pride SV Ohlsson 1999 Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease N Engl J Med 340 1948 1953
149. Lung Health Study Research Group 2000 Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease N Engl J Med 343 1902 1909
150. ER Sutherland 2003 Inhaled corticosteroids in chronic obstructive pulmonary disease Ann Intern Med 139 864 865
151. KB Highland C Strange JE Heffner 2003 Long-term effects of inhaled
152. BR Celli NE Thomas JA Anderson GT Ferguson CR Jenkins PW Jones J Vestbo K Knobil JC Yates PM Calverley 2008 Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study Am J Respir Crit Care Med 178 332 338
153. W Szafranski A Cukier A Ramirez G Menga R Sansores S Nahabedian S Peterson H Olsson 2003 Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease Eur Respir J 21 74 81 (Pubitemid 36150304)
154. PM Calverley JA Anderson B Celli GT Ferguson C Jenkins PW Jones JC Yates J Vestbo 2007 Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease N Engl J Med 356 775 789 (Pubitemid 46294610)
155. P van der Valk E Monninkhof J van der Palen G Zielhuis C van Herwaarden 2002 Effect of discontinuation of inhaled corticosteroids in patients with chronic obstructive pulmonary disease: the COPE study Am J Respir Crit Care Med 166 1358 1363
156. PL Paggiaro R Dahle I Bakran L Frith K Hollingworth J Efthimiou 1998 Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. International COPD Study Group Lancet 351 773 780
157. PM Calverley S Rennard HS Nelson JP Karpel EH Abbate P Stryszak H Staudinger 2008 One-year treatment with mometasone furoate in chronic obstructive pulmonary disease Respir Res 9 73
158. TJ Wilt D Niewoehner R MacDonald RL Kane 2007 Management of stable chronic obstructive pulmonary disease: a systematic review for a clinical practice guideline Ann Intern Med 147 639 653
159. PM Calverley F Sanchez-Toril A McIvor P Teichmann D Bredenbroeker LM Fabbri 2007 Effect of 1-year treatment with roflumilast in severe chronic obstructive pulmonary disease Am J Respir Crit Care Med 176 154 161
160. DD Sin FA McAlister SF Man NR Anthonisen 2003 Contemporary management of chronic obstructive pulmonary disease: scientific review JAMA 290 2301 2312
161. P van der Valk E Monninkhof J van der Palen G Zielhuis C van Herwaarden 2002 Effect of discontinuation of inhaled corticosteroids in patients with chronic obstructive pulmonary disease: the COPE study Am J Respir Crit Care Med 166 1358 1363
162. PW Jones LR Willits PS Burge PM Calverley 2003 Disease severity and the effect of fluticasone propionate on chronic obstructive pulmonary disease exacerbations Eur Respir J 21 68 73
163. EF Wouters DS Postma B Fokkens WC Hop J Prins AF Kuipers HR Pasma CA Hensing EC Creutzberg 2005 Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial Thorax 60 480 487
164. A O'Brien P Russo-Magno A Karki S Hiranniramol M Hardin M Kaszuba C Sherman S Rounds 2001 Effects of withdrawal of inhaled steroids in men with severe irreversible airflow obstruction Am J Respir Crit Care Med 164 365 371
165. DD Sin JV Tu 2001 Inhaled corticosteroids and the risk of mortality and readmission in elderly patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 164 580 584
166. JB Soriano VA Kiri NB Pride J Vestbo 2003 Inhaled corticosteroids with/without long-acting beta-agonists reduce the risk of rehospitalization and death in COPD patients Am J Respir Med 2 67 74
167. JB Soriano J Vestbo NB Pride V Kiri C Maden WC Maier 2002 Survival in COPD patients after regular use of fluticasone propionate and salmeterol in general practice Eur Respir J 20 819 825
168. S Suissa 2004 Inhaled steroids and mortality in COPD: bias from unaccounted immortal time Eur Respir J 23 391 395
169. DD Sin SF Man 2007 Systemic inflammation and mortality in chronic obstructive pulmonary disease Can J Physiol Pharmacol 85 141 147
170. PM Calverley W Boonsawat Z Cseke N Zhong S Peterson H Olsson 2003 Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease Eur Respir J 22 912 919 (Pubitemid 37540641)
171. PW Jones 1991 Measurement of quality of life in chronic obstructive lung disease Eur Resp Rev 1 445 453
172. JM Fitzgerald A Becker MR Sears S Mink K Chung J Lee 2004 Doubling the dose of budesonide versus maintenance treatment in asthma exacerbations Thorax 59 550 556
173. TW Harrison J Oborne S Newton AE Tattersfield 2004 Doubling the dose of inhaled corticosteroid to prevent asthma exacerbations: randomised controlled trial Lancet 363 271 275
174. G Rice-McDonald S Bowler G Staines C Mitchell 2005 Doubling daily inhaled corticosteroid dose is ineffective in mild to moderately severe attacks of asthma in adults Intern Med J 35 693 698
175. PG Gibson N Saltos K Fakes 2001 Acute anti-inflammatory effects of inhaled budesonide in asthma: a randomized controlled trial Am J Respir Crit Care Med 163 32 36
176. G Rodrigo C Rodrigo 1998 Inhaled flunisolide for acute severe asthma Am J Respir Crit Care Med 157 698 703
177. GJ Rodrigo C Rodrigo 2000 Rapid-onset asthma attack: a prospective cohort study about characteristics and response to emergency department treatment Chest 118 1547 1552
178. Edmonds ML, Camargo CA Jr, Pollack CV Jr, Rowe BH (2003) Early use of inhaled corticosteroids in the emergency department treatment of acute asthma. Cochrane Database Syst Rev CD002308
179. A Di Franco E Bacci ML Bartoli S Cianchetti FL Dente M Taccola B Vagaggini M Zingoni PL Paggiaro 2006 Inhaled fluticasone propionate is effective as well as oral prednisone in reducing sputum eosinophilia during exacerbations of asthma which do not require hospitalization Pulm Pharmacol Ther 19 353 360
180. ML Levy C Stevenson T Maslen 1996 Comparison of short courses of oral prednisolone and fluticasone propionate in the treatment of adults with acute exacerbations of asthma in primary care Thorax 51 1087 1092
181. A Foresi MC Morelli E Catena 2000 Low-dose budesonide with the addition of an increased dose during exacerbations is effective in long-term asthma control. On behalf of the Italian Study Group Chest 117 440 446
182. HK Reddel DJ Barnes 2006 Pharmacological strategies for self-management of asthma exacerbations Eur Respir J 28 182 199
183. F Maltais J Ostinelli J Bourbeau AB Tonnel N Jacquemet J Haddon M Rouleau M Boukhana JB Martinot P Duroux 2002 Comparison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial Am J Respir Crit Care Med 165 698 703
184. R Donnelly KM Williams AB Baker CA Badcock RO Day JP Seale 1997 Effects of budesonide and fluticasone on 24-hour plasma cortisol. A dose-response study Am J Respir Crit Care Med 156 1746 1751
185. DJ Clark A Grove RI Cargill BJ Lipworth 1996 Comparative adrenal suppression with inhaled budesonide and fluticasone propionate in adult asthmatic patients Thorax 51 262 266
186. GR Todd 2003 Adrenal crisis due to inhaled steroids is underestimated Arch Dis Child 88 554 555
187. GR Todd CL Acerini R Ross-Russell S Zahra JT Warner D McCance 2002 Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom Arch Dis Child 87 457 461
188. RG Cumming P Mitchell SR Leeder 1997 Use of inhaled corticosteroids and the risk of cataracts N Engl J Med 337 8 14 (Pubitemid 27290841)
189. E Garbe J LeLorier JF Boivin S Suissa 1997 Inhaled and nasal glucocorticoids and the risks of ocular hypertension or open-angle glaucoma JAMA 277 722 727 (Pubitemid 27106224)
190. CA Wong LJ Walsh CJ Smith AF Wisniewski SA Lewis R Hubbard S Cawte DJ Green M Pringle AE Tattersfield 2000 Inhaled corticosteroid use and bone-mineral density in patients with asthma Lancet 355 1399 1403
191. S Pedersen 2006 Clinical safety of inhaled corticosteroids for asthma in children: an update of long-term trials Drug Saf 29 599 612
192. AE Tattersfield GI Town O Johnell C Picado M Aubier P Braillon R Karlstrom 2001 Bone mineral density in subjects with mild asthma randomised to treatment with inhaled corticosteroids or non-corticosteroid treatment for two years Thorax 56 272 278
193. S Elmstahl H Ekstrom H Galvard O Johnell M Gerhardsson de Verdier E Norjavaara 2003 Is there an association between inhaled corticosteroids and bone density in postmenopausal women? J Allergy Clin Immunol 111 91 96
194. HW Kelly ML Van Natta RA Covar J Tonascia RP Green RC Strunk 2008 Effect of long-term corticosteroid use on bone mineral density in children: a prospective longitudinal assessment in the childhood Asthma Management Program (CAMP) study Ped 122 e53 e61
195. TP van Staa HG Leufkens C Cooper 2001 Use of inhaled corticosteroids and risk of fractures J Bone Miner Res 16 581 588
196. S Suissa M Baltzan R Kremer P Ernst 2004 Inhaled and nasal corticosteroid use and the risk of fracture Am J Respir Crit Care Med 169 83 88 (Pubitemid 38233893)
197. TA Lee KB Weiss SD Sullivan 2004 Cost-effectiveness of inhaled corticosteroids in chronic obstructive pulmonary disease Am J Med 117 618 619
198. M Etminan M Sadatsafavi ZS Ganjizadeh B Takkouche JM Fitzgerald 2008 Inhaled corticosteroids and the risk of fractures in older adults: a systematic review and meta-analysis Drug Saf 31 409 414
199. HS Nelson ST Weiss ER Bleecker SW Yancey PM Dorinsky 2006 The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol Chest 129 15 26
200. JM Kramer 2009 Balancing the benefits and risks of inhaled long-acting beta-agonists-the influence of values N Engl J Med 360 1592 1595
201. MJ Paul-Clark F Roviezzo RJ Flower G Cirino PD Soldato IM Adcock M Perretti 2003 Glucocorticoid receptor nitration leads to enhanced anti-inflammatory effects of novel steroid ligands J Immunol 171 3245 3252
202. BJ Nevin KJ Broadley 2004 Comparative effects of inhaled budesonide and the NO-donating budesonide derivative, NCX 1020, against leukocyte influx and airway hyperreactivity following lipopolysaccharide challenge Pulm Pharmacol Ther 17 219 232
203. IM Adcock G Caramori KF Chung 2008 New targets for drug development in asthma Lancet 372 1073 1087
204. H Derendorf 2007 Pharmacokinetic and pharmacodynamic properties of inhaled ciclesonide J Clin Pharmacol 47 782 789
205. H Schacke M Berger H Rehwinkel K Asadullah 2007 Selective glucocorticoid receptor agonists (SEGRAs): novel ligands with an improved therapeutic index Mol Cell Endocrinol 275 109 117
206. H Schacke A Schottelius WD Docke P Strehlke S Jaroch N Schmees H Rehwinkel H Hennekes K Asadullah 2004 Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects Proc Natl Acad Sci USA 101 227 232
207. H Schacke WD Docke K Asadullah 2002 Mechanisms involved in the side effects of glucocorticoids Pharmacol Ther 96 23 43
208. JN Miner B Ardecky K Benbatoul K Griffiths CJ Larson DE Mais K Marschke J Rosen E Vajda L Zhi, et al. 2007 Antiinflammatory glucocorticoid receptor ligand with reduced side effects exhibits an altered protein-protein interaction profile Proc Natl Acad Sci USA 104 19244 19249
209. S Ogawa J Lozach C Benner G Pascual RK Tangirala S Westin A Hoffmann S Subramaniam M David MG Rosenfeld, et al. 2005 Molecular determinants of crosstalk between nuclear receptors and toll-like receptors Cell 122 707 721
210. SN Farrow 2008 Nuclear receptors: doubling up in the lung Curr Opin Pharmacol 8 275 279
211. T Renda S Baraldo G Pelaia E Bazzan G Turato A Papi P Maestrelli R Maselli A Vatrella LM Fabbri, et al. 2008 Increased activation of p38 MAPK in COPD Eur Respir J 31 62 69
212. K Ito G Caramori IM Adcock 2007 Therapeutic potential of phosphatidylinositol 3-kinase inhibitors in inflammatory respiratory disease J Pharmacol Exp Ther 321 1 8
213. IM Adcock G Caramori KF Chung 2008 New targets for drug development in asthma Lancet 372 1073 1087
214. JA Marwick CS Stevenson PJ Barnes K Ito IM Adcock PA Kirkham 2008 Cigarette smoke reduces steroid sensitivity by reducing glucocorticoid receptor (GR) and GR co-repressor expression Proc Am Thorac Soc 5 A333
215. E Irusen JG Matthews A Takahashi PJ Barnes KF Chung IM Adcock 2002 p38 Mitogen-activated protein kinase-induced glucocorticoid receptor phosphorylation reduces its activity: role in steroid-insensitive asthma J Allergy Clin Immunol 109 649 657
216. Kent L, Smyth L, Plumb J, Clayton C, Fox S, Ray D, Farrow S, Singh D (2008) Inhibition of LPS stimulated COPD macrophage inflammatory gene expression by dexamethasone and the p38 MAPK inhibitor SB706504. J Pharmacol Exp Ther. doi: 10.1124/jpet.108.142950
217. TK Loke KH Mallett J Ratoff BJ O'Connor S Ying Q Meng C Soh TH Lee CJ Corrigan 2006 Systemic glucocorticoid reduces bronchial mucosal activation of activator protein 1 components in glucocorticoid-sensitive but not glucocorticoid-resistant asthmatic patients J Allergy Clin Immunol 118 368 375
218. BG Cosio L Tsaprouni K Ito E Jazrawi IM Adcock PJ Barnes 2004 Theophylline restores histone deacetylase activity and steroid responses in COPD macrophages J Exp Med 200 689 695
219. T Ahmad PJ Barnes IM Adcock 2008 Overcoming steroid insensitivity in smoking asthmatics Curr Opin Investig Drugs 9 470 477
220. I Rahman IM Adcock 2006 Oxidative stress and redox regulation of lung inflammation in COPD Eur Respir J 28 219 242
221. BM Rothschild 2008 Review: individual DMARDs have similar efficacy for RA, but combination therapy improves response Evid Based Med 13 76